Aeolus Pharmaceuticals (AOLS) Stock Price, News & Analysis

Company Overview

Aeolus Pharmaceuticals, Inc. is a biotechnology company that historically focused on developing medical countermeasures for serious conditions associated with oxidative stress, including injuries caused by radiation, chemical agents and other toxic exposures.

The company’s primary investigational product was AEOL 10150, a synthetic catalytic antioxidant designed to mimic certain protective properties of antioxidant enzymes in the body. Aeolus evaluated the compound for potential use in treating pulmonary and other forms of tissue injury, including damage associated with radiation exposure and chemical warfare agents.

Aeolus Pharmaceuticals’ development programs were primarily oriented toward government-sponsored preparedness initiatives and specialized therapeutic applications rather than conventional commercial pharmaceutical markets. Publicly available information about its current operations, geographic activities and leadership is limited, and the company’s development status may have changed since its earlier research programs.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 8/14/2017
• Today: 10/08/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:AOLS
• CIK: 1261734
• Web: www.aeoluspharma.com
• Phone: (949) 481-9825
• Fax: 949-481-9829
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A